Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Journal of Pharmacy and Science

• Publication date

  1984-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/JPS.2600730821PMID 6491914
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure.

  2009cited by this paper
• The pharmacokinetics and pharmacodynamics of bumetanide in normal subjects

  1982cited by this paper
• Long‐Term Bumetanide Treatment of Renal Edema. Comparison with Furosemide

  1981cited by this paper
• Renal Effects of Bumetanide

  1981cited by this paper
• Pharmacokinetics of intravenously administered bumetanide in man

  1980cited by this paper
• Effect of plasma protein binding on renal clearance of drugs.

  1980cited by this paper
• Noncompartmental determination of the steady-state volume of distribution.

  1979cited by this paper
• Diuretic effect and metabolism of bumetanide in man

  1977cited by this paper
• Fate of [14C]-bumetanide in man.

  1977cited by this paper
• Renal tubular handling of drugs.

  1977cited by this paper
• Bumetanide: radioimmunoassay and pharmacokinetic profile in humans.

  1976cited by this paper
• Bumetanide--acute and long term studies of a new high potency diuretic.

  1975cited by this paper
• Bumetanide—acute and long term studies of a new high potency diuretic

  1975cited by this paper
• Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays.

  1974cited by this paper
• Bioavailability--a problem in equivalence.

  1974cited by this paper
• Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide

  1974cited by this paper
• The sites of action of bumetanide in man.

  1973cited by this paper
• Renal effects of bumetanide, a new saluretic agent

  1973cited by this paper
• GLC determination and urinary recovery of bumetanide in healthy volunteers.

  1973cited by this paper
• Influence of route of administration on drug availability.

  1972cited by this paper
• Bumetanide: Potent New “Loop” Diuretic

  1972cited by this paper

• Predicting Pharmacokinetics of Drugs in Patients with Heart Failure and Optimizing Their Dosing Strategies Using a Physiologically Based Pharmacokinetic Model

  2025cites this paper
• Diuretics in patients with chronic kidney disease

  2025cites this paper
• The Changing Role of Loop Diuretics in Heart Failure Management across the Last Century

  2024cites this paper
• Diuretics in pediatrics

  2023cites this paper
• Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease

  2023cites this paper
• Human Apparent Volume of Distribution Predicts Bioaccumulation of Ionizable Organic Chemicals in Zebrafish Embryos.

  2022cites this paper
• Modulation of Urate Transport by Drugs

  2021cites this paper
• The Prescription of Drugs That Inhibit Organic Anion Transporters 1 or 3 Is Associated with the Plasma Accumulation of Uremic Toxins in Kidney Transplant Recipients

  2021cites this paper
• Contribution of Monocarboxylate Transporter 6 to the Pharmacokinetics and Pharmacodynamics of Bumetanide in Mice

  2020influential citation
• A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy

  2019cites this paper
• Application of a physiologically‐based pharmacokinetic model for the prediction of bumetanide plasma and brain concentrations in the neonate

  2018cites this paper
• Bumepamine, a brain‐permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti‐seizure efficacy

  2018cites this paper
• Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders

  2017cites this paper
• Supramolecular Synthons in Bumetanide Cocrystals and Ternary Products

  2017cites this paper
• The Efficacy of Diuretics in Acute and Chronic Renal Failure

  2012cites this paper
• Individualization of a pharmacokinetic model by fractional and nonlinear fit improvement

  2012cites this paper
• Update in diuretic therapy: clinical pharmacology.

  2011cites this paper
• Diuretics in acute kidney injury.

  2011cites this paper
• Masking and manipulation.

  2010cites this paper
• Diuretics in clinical practice. Part I: mechanisms of action, pharmacological effects and clinical indications of diuretic compounds

  2010cites this paper
• Computational prediction of oral drug absorption based on absorption rate constants in humans.

  2006cites this paper
• Determination of Bumetanide in Human Plasma by a Validated HPLC Method and Its Application to Single-dose Pharmacokinetics

  2005cites this paper
• Metabolism of the diuretic bumetanide in healthy subjects and patients with renal impairment

  2004cites this paper
• Loop diuretics: from the Na-K-2Cl transporter to clinical use.

  2003cites this paper
• Effect of food on the absorption of frusemide and bumetanide in man.

  2003cites this paper
• Positive effect of bumetanide on contractile activity of ventricular cardiomyocytes.

  2000cites this paper
• Diuretic therapy.

  1998cites this paper
• Detection of diuretic agents in doping control.

  1996cites this paper
• Factors affecting the absorption and disposition of frusemide and bumetanide in man

  1996cites this paper
• Pharmacokinetics of bumetanide in critically ill infants

  1996cites this paper
• Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous bumetanide.

  1995cites this paper
• Pharmacokinetics and pharmacodynamics of the diuretic bumetanide in the elderly

  1995cites this paper
• Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: Absorption from various GI segments

  1994cites this paper
• Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam

  1991cites this paper
• The pharmacology and therapeutics of diuretics in the pediatric patient.

  1990cites this paper
• Analysis of bumetanide in human urine by high-performance liquid chromatography with fluorescence detection and gas chromatography/mass spectrometry.

  1990cites this paper
• Estimate of Volume/Flow Ratio of Gastrointestinal (GI) Fluids in Humans Using Pharmacokinetic Data

  1990cites this paper
• The absolute oral bioavailability of selected drugs.

  1989cites this paper
• Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with congestive heart failure

  1988cites this paper
• Renal disease and drug metabolism: an overview.

  1986cites this paper
• Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with chronic renal failure

  1986cites this paper
• Pharmacokinetics and diuretic effect of bumetanide following intravenous and intramuscular administration to horses.

  1986cites this paper
• Disposition and response to bumetanide and furosemide.

  1986cites this paper